"Anecdotal stories suggesting that weight-loss drugs can help people shake long-standing addictions have been spreading fast in the past few years, through online forums, weight-loss clinics and news headlines. And now, clinical data are starting to back them up."
"Over a dozen randomized clinical studies testing whether GLP-1 drugs like Ozempic can suppress addiction are now under way, and neuroscientists are working out how these weight-loss drugs act on brain regions that control craving, reward and motivation. Scientists warn that the research is still in its early stages, but some researchers and physicians are excited, as no truly new class of addiction medicine has won approval from regulators in decades."
Anecdotal reports suggest GLP-1 weight-loss drugs can reduce longstanding addictions and have spread rapidly via online forums, clinics and headlines. Early clinical data are beginning to support these observations. More than a dozen randomized clinical trials are underway to test whether GLP-1 drugs such as Ozempic can suppress addictive behaviors. Neuroscientists are investigating how these drugs influence brain regions that govern craving, reward and motivation. Researchers caution that the evidence remains preliminary, but some clinicians and scientists are optimistic because no fundamentally new class of addiction medication has been approved in decades.
Read at Nature
Unable to calculate read time
Collection
[
|
...
]